Find a trial at the Pfizer Clinical Research Unit
2 trials found
Study with a medical device containing 104 mg MPA (medroxyprogesterone acetate) in 0.65 mL suspension for injection and indicated for long-term female contraception via SC injection into the anterior thigh or abdomen every 13 weeks.
The Pfizer Clinical Research Unit of Brussels will be conducting research studies in the near future with participants of Chinese descent.
Interested in participating?
Either dial the toll-free number 00800/2636 2636 (from Belgium, France, Germany, The Netherlands, Italy, and Japan) or +32 2 566 78 46 (from other countries) and speak with a representative of the PCRU to learn more. Alternatively, click here to see if you may qualify for our research unit’s ongoing clinical trials.